MT-ND6 and glioblastoma: Fewer sites showed significantly lower levels of DNA methylation in the 143BGBM tumors, including one site in each of CO1, ND4, ND5, ND6, and CYTB. There were also uniquely differentially methylated sites identified in the 143BGBM early and late tumors when compared with GBM cells.